These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 16061096

  • 1. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP.
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [Abstract] [Full Text] [Related]

  • 2. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
    Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB, Thorne JE.
    Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L, Christen W, Foster CS.
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil for ocular inflammation.
    Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH.
    Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
    Saw VP, Dart JK, Rauz S, Ramsay A, Bunce C, Xing W, Maddison PG, Phillips M.
    Ophthalmology; 2008 Feb; 115(2):253-261.e1. PubMed ID: 17655931
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
    Cuchacovich M, Solanes F, Perez C, Verdaguer JI, Verdaguer J, Castiglione E, Carpentier C, Traipe L, Villarroel F.
    J Ocul Pharmacol Ther; 2016 Feb; 32(1):55-61. PubMed ID: 26562247
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR.
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil for the treatment of uveitis.
    Teoh SC, Hogan AC, Dick AD, Lee RW.
    Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
    [Abstract] [Full Text] [Related]

  • 9. Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid.
    Doycheva D, Deuter C, Blumenstock G, Stuebiger N, Zierhut M.
    Ocul Immunol Inflamm; 2011 Dec; 19(6):431-8. PubMed ID: 22106912
    [Abstract] [Full Text] [Related]

  • 10. Methotrexate for ocular inflammatory diseases.
    Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH, Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study.
    Ophthalmology; 2009 Nov; 116(11):2188-98.e1. PubMed ID: 19748676
    [Abstract] [Full Text] [Related]

  • 11. Cyclophosphamide for ocular inflammatory diseases.
    Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS.
    Ophthalmology; 2010 Feb; 117(2):356-65. PubMed ID: 19969366
    [Abstract] [Full Text] [Related]

  • 12. Azathioprine for ocular inflammatory diseases.
    Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB.
    Am J Ophthalmol; 2009 Oct; 148(4):500-509.e2. PubMed ID: 19570522
    [Abstract] [Full Text] [Related]

  • 13. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
    Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Deuter C.
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813
    [Abstract] [Full Text] [Related]

  • 14. [Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid].
    Zurdel J, Aboalchamat B, Zierhut M, Stübiger N, Bialasiewicz A, Engelmann K.
    Klin Monbl Augenheilkd; 2001 Apr; 218(4):222-8. PubMed ID: 11392266
    [Abstract] [Full Text] [Related]

  • 15. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE, Woreta FA, Jabs DA, Anhalt GJ.
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [Abstract] [Full Text] [Related]

  • 16. Treatment of mucous membrane pemphigoid with mycophenolate mofetil.
    Nottage JM, Hammersmith KM, Murchison AP, Felipe AF, Penne R, Raber I.
    Cornea; 2013 Jun; 32(6):810-5. PubMed ID: 23132447
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil.
    Hatton MP, Rubin PA, Foster CS.
    Am J Ophthalmol; 2005 Nov; 140(5):916-8. PubMed ID: 16310473
    [Abstract] [Full Text] [Related]

  • 18. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.
    Gangaputra SS, Newcomb CW, Joffe MM, Dreger K, Begum H, Artornsombudh P, Pujari SS, Daniel E, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Kempen JH, SITE Cohort Research Group.
    Am J Ophthalmol; 2019 Dec; 208():68-75. PubMed ID: 31344346
    [Abstract] [Full Text] [Related]

  • 19. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M, Schmiedeberg S, Becker J, Ruzicka T.
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.
    Larkin G, Lightman S.
    Ophthalmology; 1999 Feb; 106(2):370-4. PubMed ID: 9951492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.